As the government bans smoking in public places, the situation at educational institutions doesn’t look too good ...

Pre-Clinical Drug Discovery Services Market to grow through 2035, driven by rising chronic diseases and increased outsourcing of early-stage R&D.

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

Veteran actress Sharmila Tagore's early-stage lung cancer diagnosis has brought attention to zero-stage lung cancer, also known as carcinoma in situ. Discovered during a routine check, this pre ...

Cindy was a healthy, 35-year-old woman with no symptoms of cancer when she joined the American Lung Association’s Lung Health Cohort Study.

Lung cancer is the leading cause of cancer-related death in the U.S. This makes lung cancer screening important.

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

Among eligible populations, screening for breast and colorectal cancers was nearly four times more common than for lung cancer. Among those who never had lung cancer screening, roughly 60% had ...

Although immunotherapies and biomarker-driven interventions have transformed lung cancer outcomes, Martin Edelman, MD, Fox Chase Cancer Center, highlighted the present challenge hindering clinicians' ...

Rory Londer's third "walk of gratitude" around the Mayo Clinic campus coincides with an expansion of support services for ...

Previous estimates had put this risk closer to ... Master Regulator Blocking Immunotherapy, Paving the Way for a New Lung Cancer Treatment Apr. 9, 2025 — Researchers have discovered that 'DEAD ...